Salem Investment Counselors Inc. Boosts Stock Holdings in Synopsys, Inc. $SNPS

Salem Investment Counselors Inc. grew its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 35,910.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,601 shares of the semiconductor company’s stock after purchasing an additional 3,591 shares during the quarter. Salem Investment Counselors Inc.’s holdings in Synopsys were worth $1,606,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the business. Sankala Group LLC purchased a new position in Synopsys during the fourth quarter valued at approximately $25,000. Elevation Wealth Partners LLC lifted its holdings in Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after buying an additional 27 shares during the period. Caitong International Asset Management Co. Ltd bought a new stake in Synopsys during the 4th quarter valued at $28,000. Atlas Capital Advisors Inc. purchased a new position in shares of Synopsys in the 4th quarter valued at $32,000. Finally, Phillip James Consulting Co. purchased a new position in shares of Synopsys in the 4th quarter valued at $36,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Insider Buying and Selling

In other news, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.56% of the company’s stock.

Synopsys Price Performance

Shares of SNPS opened at $412.32 on Thursday. The business’s 50-day moving average is $428.15 and its two-hundred day moving average is $444.13. The company has a market capitalization of $78.95 billion, a P/E ratio of 95.44, a P/E/G ratio of 2.41 and a beta of 1.23. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $628.89. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. During the same quarter in the previous year, the firm posted $3.67 EPS. The company’s revenue for the quarter was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Research analysts predict that Synopsys, Inc. will post 10.65 earnings per share for the current year.

Wall Street Analyst Weigh In

SNPS has been the subject of a number of analyst reports. Benchmark began coverage on Synopsys in a research note on Wednesday, July 15th. They set a “buy” rating and a $570.00 price objective for the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of Synopsys in a research note on Monday, June 8th. Stifel Nicolaus increased their target price on shares of Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. BNP Paribas Exane upped their price target on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research report on Thursday, May 28th. Finally, Bank of America boosted their target price on Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $565.06.

Key Stories Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Synopsys is expanding its use of AI in chip design, verification and simulation. These tools can improve engineering productivity and reinforce the company’s role in the semiconductor supply chain as demand for AI chips grows. Can SNPS Leverage AI to Accelerate Chip Design and Drive Growth?
• Positive Sentiment: The company is making a major push into agentic AI engineering software, developed in collaboration with Nvidia. The technology could create new growth opportunities by automating portions of chip-to-system development and strengthening Synopsys’ exposure to AI infrastructure. Synopsys Bets Big on Agentic AI
• Positive Sentiment: Despite a recent decline in the shares, analysts and market commentary continue to point to Synopsys’ recurring revenue base, AI exposure and Ansys acquisition as supports for longer-term growth. Its latest reported quarter also included revenue growth of 41.9% year over year and an earnings beat.
• Positive Sentiment: The broader Nvidia-led AI ecosystem remains a potential tailwind for Synopsys because the company provides software used to design and validate advanced chips. Nvidia’s expanding influence in AI investment and data centers could increase demand for semiconductor design tools. Nvidia Will Be the World’s First $10 Trillion Company
• Neutral Sentiment: Synopsys announced that General Counsel Janet Lee will step down, with Cor… identified as part of the transition. The leadership change may receive limited market attention unless additional details indicate an operational or governance concern. Synopsys Announces Transition of General Counsel Role
• Neutral Sentiment: An average analyst price target of $570.06 suggests substantial potential upside, but the figure does not represent a new rating or estimate revision and therefore may have limited immediate impact.
• Negative Sentiment: Wells Fargo lowered its price target from $535 to $450 and maintained an “equal weight” rating. Although the revised target remains above the recent trading level, the cut signals more cautious expectations and may weigh on sentiment. Wells Fargo Price Target Update

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.